Bionor is a biopharmaceutical company with first mover potential to advance a possible functional HIV cure

Latest news

Hide mandatory notifications of trade

Notice of Extraordinary General Meeting 6 June 2016

Financial .2016

(Oslo, Norway, 13 May 2016) An Extraordinary General Meeting of Bionor Pharma ASA will be held on Monday 6 June 2016 at 15:00 hours at Kronprinsesse Märthas plass 1, Oslo, Norway, at the meeting room on the 9th floor.

Q1 2016 Interim Financial Report

Financial .2016

Bionor Pharma ASA
Interim Financial Report
1 January – 31 March 2016
Unaudited

11 May 2016

Update from the Board of Directors

Financial .2016

(Oslo, Norway, 28 April 2016) Bionor Pharma ASA (OSE:BIONOR) announces that the Board of Directors is currently reviewing the company’s strategy and financing plans and will announce any possible changes in due course in a stock exchange announcement.

Notice of Extraordinary General Meeting 6 June 2016

Financial .2016

(Oslo, Norway, 13 May 2016) An Extraordinary General Meeting of Bionor Pharma ASA will be held on Monday 6 June 2016 at 15:00 hours at Kronprinsesse Märthas plass 1, Oslo, Norway, at the meeting room on the 9th floor.

Q1 2016 Interim Financial Report

Financial .2016

Bionor Pharma ASA
Interim Financial Report
1 January – 31 March 2016
Unaudited

11 May 2016

Update from the Board of Directors

Financial .2016

(Oslo, Norway, 28 April 2016) Bionor Pharma ASA (OSE:BIONOR) announces that the Board of Directors is currently reviewing the company’s strategy and financing plans and will announce any possible changes in due course in a stock exchange announcement.

Go to news section

Featured content